Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States Point-Of-Care Diagnostics/Testing (POCT) Sales Market Report 2021

  • QYR634181
  • 107 Pages
  • August 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
This report studies sales (consumption) of Point-Of-Care Diagnostics / Testing (POCT) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Laboratories, Inc

Abaxis, Inc

Alere, Inc

Bayer AG

Danaher Corporation

Becton, Dickinson And Company

Johnson & Johnson

Nipro Corporation

Roche Diagnostics Limited

Siemens Healthcare

Samsung Medison Co. Ltd

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Glucose Monitoring

Cardiac Markers

Infectious Diseases Testing

Cholesterol Testing

Coagulation Monitoring

Others

Split by applications, this report focuses on sales, market share and growth rate of Point-Of-Care Diagnostics / Testing (POCT) in each application, can be divided into

Clinics

Home

Laboratories

Assisted living healthcare facilities

Hospitals

Table of Contents

United States Point-Of-Care Diagnostics / Testing (POCT) Sales Market Report 2021

1 Point-Of-Care Diagnostics / Testing (POCT) Overview

1.1 Product Overview and Scope of Point-Of-Care Diagnostics / Testing (POCT)

1.2 Classification of Point-Of-Care Diagnostics / Testing (POCT)

1.2.1 Glucose Monitoring

1.2.2 Cardiac Markers

1.2.3 Infectious Diseases Testing

1.2.4 Cholesterol Testing

1.2.5 Coagulation Monitoring

1.2.6 Others

1.3 Applications of Point-Of-Care Diagnostics / Testing (POCT)

1.3.1 Clinics

1.3.2 Home

1.3.3 Laboratories

1.3.4 Assisted living healthcare facilities

1.3.5 Hospitals

1.4 USA Market Size (Value and Volume) of Point-Of-Care Diagnostics / Testing (POCT) (2011-2021)

1.4.1 USA Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue and Price (2011-2021)

1.4.2 USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Growth Rate (2011-2021)

1.4.3 USA Point-Of-Care Diagnostics / Testing (POCT) Revenue and Growth Rate (2011-2021)

2 USA Point-Of-Care Diagnostics / Testing (POCT) Competition by Manufacturers

2.1 USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Point-Of-Care Diagnostics / Testing (POCT) Revenue and Share by Manufactures (2015 and 2016)

3 USA Point-Of-Care Diagnostics / Testing (POCT) (Volume and Value) by Type

3.1 USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Market Share by Type (2011-2021)

3.2 USA Point-Of-Care Diagnostics / Testing (POCT) Revenue and Market Share by Type (2011-2021)

4 USA Point-Of-Care Diagnostics / Testing (POCT) (Volume) by Application

5 USA Point-Of-Care Diagnostics / Testing (POCT) Manufacturers Analysis

5.1 Abbott Laboratories, Inc

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Point-Of-Care Diagnostics / Testing (POCT) Product Type and Technology

5.1.2.1 Glucose Monitoring

5.1.2.2 Cardiac Markers

5.1.3 Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)

5.2 Abaxis, Inc

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Medical Devices Product Type and Technology

5.2.2.1 Glucose Monitoring

5.2.2.2 Cardiac Markers

5.2.3 Medical Devices Sales, Revenue, Price of Abaxis, Inc (2015 and 2016)

5.3 Alere, Inc

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Alere, Inc Product Type and Technology

5.3.2.1 Glucose Monitoring

5.3.2.2 Cardiac Markers

5.3.3 Alere, Inc Sales, Revenue, Price of Alere, Inc (2015 and 2016)

5.4 Bayer AG

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Roche Diagnostics Limited Product Type and Technology

5.4.2.1 Glucose Monitoring

5.4.2.2 Cardiac Markers

5.4.3 Bayer AG Sales, Revenue, Price of Bayer AG (2015 and 2016)

5.5 Danaher Corporation

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Danaher Corporation Product Type and Technology

5.5.2.1 Glucose Monitoring

5.5.2.2 Cardiac Markers

5.5.3 Danaher Corporation Sales, Revenue, Price of Danaher Corporation (2015 and 2016)

5.6 Becton, Dickinson And Company

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Becton, Dickinson And Company Product Type and Technology

5.6.2.1 Glucose Monitoring

5.6.2.2 Cardiac Markers

5.6.3 Becton, Dickinson And Company Sales, Revenue, Price of Becton, Dickinson And Company (2015 and 2016)

5.7 Johnson & Johnson

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Johnson & Johnson Product Type and Technology

5.7.2.1 Glucose Monitoring

5.7.2.2 Cardiac Markers

5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.8 Nipro Corporation

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Nipro Corporation Product Type and Technology

5.8.2.1 Glucose Monitoring

5.8.2.2 Cardiac Markers

5.8.3 Nipro Corporation Sales, Revenue, Price of Nipro Corporation (2015 and 2016)

5.9 Roche Diagnostics Limited

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Roche Diagnostics Limited Product Type and Technology

5.9.2.1 Glucose Monitoring

5.9.2.2 Cardiac Markers

5.9.3 Roche Diagnostics Limited Sales, Revenue, Price of Roche Diagnostics Limited (2015 and 2016)

5.10 Siemens Healthcare

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Siemens Healthcare Product Type and Technology

5.10.2.1 Glucose Monitoring

5.10.2.2 Cardiac Markers

5.10.3 Siemens Healthcare Sales, Revenue, Price of Siemens Healthcare (2015 and 2016)

5.11 Samsung Medison Co. Ltd

6 Point-Of-Care Diagnostics / Testing (POCT) Technology and Development Trend

6.1 Point-Of-Care Diagnostics / Testing (POCT) Technology Analysis

6.2 Point-Of-Care Diagnostics / Testing (POCT) Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Point-Of-Care Diagnostics / Testing (POCT)

Table Classification of Point-Of-Care Diagnostics / Testing (POCT)

Figure USA Sales Market Share of Point-Of-Care Diagnostics / Testing (POCT) by Type in 2015

Figure Glucose Monitoring Picture

Figure Cardiac Markers Picture

Figure Infectious Diseases Testing Picture

Figure Cholesterol Testing Picture

Figure Coagulation Monitoring Picture

Figure Others Picture

Table Applications of Point-Of-Care Diagnostics / Testing (POCT)

Figure USA Sales Market Share of Point-Of-Care Diagnostics / Testing (POCT) by Application in 2015

Figure Clinics Examples

Figure Home Examples

Figure Laboratories Examples

Figure Assisted living healthcare facilities Examples

Figure Hospitals Examples

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue and Price (2011-2021)

Figure USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Growth Rate (2011-2021)

Figure USA Point-Of-Care Diagnostics / Testing (POCT) Revenue and Growth Rate (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales of Key Manufacturers (2015 and 2016)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Point-Of-Care Diagnostics / Testing (POCT) Sales Share by Manufacturers

Figure 2016 Point-Of-Care Diagnostics / Testing (POCT) Sales Share by Manufacturers

Table USA Point-Of-Care Diagnostics / Testing (POCT) Revenue by Manufacturers (2015 and 2016)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Point-Of-Care Diagnostics / Testing (POCT) Revenue Share by Manufacturers

Table 2016 USA Point-Of-Care Diagnostics / Testing (POCT) Revenue Share by Manufacturers

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Market Share by Type (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales Share by Type (2011-2021)

Figure Sales Market Share of Point-Of-Care Diagnostics / Testing (POCT) by Type (2011-2021)

Figure USA Point-Of-Care Diagnostics / Testing (POCT) Sales Growth Rate by Type (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Revenue and Market Share by Type (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Point-Of-Care Diagnostics / Testing (POCT) by Type (2011-2021)

Figure USA Point-Of-Care Diagnostics / Testing (POCT) Revenue Growth Rate by Type (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales and Market Share by Application (2011-2021)

Table USA Point-Of-Care Diagnostics / Testing (POCT) Sales Share by Application (2011-2021)

Figure Sales Market Share of Point-Of-Care Diagnostics / Testing (POCT) by Application (2011-2021)

Figure USA Point-Of-Care Diagnostics / Testing (POCT) Sales Growth Rate by Application (2011-2021)

Table Abbott Laboratories, Inc Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)

Table Abaxis, Inc Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Abaxis, Inc (2015 and 2016)

Table Alere, Inc Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Alere, Inc (2015 and 2016)

Table Bayer AG Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Bayer AG (2015 and 2016)

Table Danaher Corporation Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Danaher Corporation (2015 and 2016)

Table Becton, Dickinson And Company Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Becton, Dickinson And Company (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table Nipro Corporation Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Nipro Corporation (2015 and 2016)

Table Roche Diagnostics Limited Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Roche Diagnostics Limited (2015 and 2016)

Table Siemens Healthcare Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Siemens Healthcare (2015 and 2016)

Table Samsung Medison Co. Ltd Basic Information List

Table Point-Of-Care Diagnostics / Testing (POCT) Sales, Revenue, Price of Samsung Medison Co. Ltd (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370